Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02096471
Title MEK Inhibitor PD-0325901 Trial in Adolescents and Adults With NF1
Acronym MEK Inhibitor
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Alabama at Birmingham
Indications
Therapies
Age Groups: adult | child
Covered Countries USA


No variant requirements are available.